Nigella Seed (Nigella sativa)

Nigella sativa seeds contain thymoquinone as the primary bioactive compound, which inhibits NF-κB signaling and modulates oxidative stress pathways to produce anti-inflammatory and metabolic effects. Clinical research supports its use for blood glucose regulation in type 2 diabetes and thyroid autoimmunity, particularly at doses of 2–3g daily.

Origin & History

Nigella sativa, commonly known as black seed or Nigella seed, is derived from an annual flowering herb native to Southwest Asia, the Middle East, and North Africa. The seeds are harvested and used whole, as powder, or extracted via solvent methods to isolate active compounds like thymoquinone, belonging to the chemical class of essential oils, flavonoids, and quinones.

Historical & Cultural Context

Nigella sativa has been used for centuries in Middle Eastern, Islamic (Unani/Tibb), Ayurvedic, and traditional Mediterranean medicine for respiratory issues, digestion, inflammation, and general vitality. Historical references date back over 2,000 years, traditionally used as an antidote and health tonic.

Health Benefits

• Reduces blood glucose and HbA1c in type 2 diabetes - RCTs with 94 patients showed significant improvements at 2-3g/day for 12 weeks (moderate evidence)
• Lowers inflammation markers in autoimmune conditions - double-blind RCT in 40 Hashimoto's thyroiditis patients reduced TSH, T3, and anti-TPO antibodies (moderate evidence)
• Improves metabolic syndrome parameters - RCT showed reduced FBG, postprandial glucose, HbA1c, and LDL-C with 500mg/day for 8 weeks (moderate evidence)
• Reduces chemotherapy side effects - clinical trial in pediatric leukemia patients showed fewer adverse effects at 40mg/kg/day for 3 months (preliminary evidence)
• Lowers blood pressure and oxidative stress - meta-analyses confirm cardiovascular benefits though larger RCTs needed (moderate evidence)

How It Works

Thymoquinone, the principal bioactive in nigella seed oil, suppresses NF-κB and MAPK signaling cascades, reducing downstream production of pro-inflammatory cytokines including TNF-α and IL-6. It also activates Nrf2-mediated antioxidant response elements, upregulating superoxide dismutase and catalase activity. Additionally, thymoquinone enhances insulin receptor sensitivity and inhibits α-glucosidase activity, contributing to its observed hypoglycemic effects.

Scientific Research

A 2017 systematic review of RCTs identified benefits for metabolic syndrome, diabetes, hypertension, and inflammatory disorders. Multiple meta-analyses (PMIDs: 27512971, 30873688, 33183658) confirm Nigella sativa lowers glycemic status, blood pressure, inflammation, and oxidative stress. Clinical trials have tested doses from 0.5-3g/day for 4-12 weeks in conditions ranging from diabetes to Hashimoto's thyroiditis.

Clinical Summary

A pooled analysis of RCTs involving 94 type 2 diabetes patients demonstrated that 2–3g/day of nigella seed powder for 12 weeks produced significant reductions in fasting blood glucose and HbA1c compared to placebo, representing moderate-quality evidence. A double-blind RCT in 40 Hashimoto's thyroiditis patients showed meaningful reductions in TSH, free T3, and anti-TPO antibody titers following nigella seed supplementation. Evidence quality is moderate overall, limited by small sample sizes and short durations; larger phase III trials are lacking. Effects on lipid profiles and blood pressure have also been reported in secondary endpoints across several studies, though these findings are less consistent.

Nutritional Profile

{"macronutrients": {"protein": "20g per 100g", "fat": "35g per 100g", "carbohydrates": "45g per 100g", "fiber": "10g per 100g"}, "micronutrients": {"vitamins": {"vitamin C": "1mg per 100g", "vitamin A": "2 IU per 100g"}, "minerals": {"calcium": "931mg per 100g", "iron": "66mg per 100g", "magnesium": "385mg per 100g", "zinc": "4mg per 100g"}}, "bioactive_compounds": {"thymoquinone": "2-5% of oil content", "nigellone": "trace amounts"}, "bioavailability_notes": "The bioavailability of thymoquinone may be enhanced when consumed with fats due to its lipophilic nature. Minerals such as iron and calcium may have reduced absorption due to the presence of phytates."}

Preparation & Dosage

Clinically studied doses: 2-3g/day seeds for 12 weeks (diabetes); 500mg/day for 8 weeks (metabolic syndrome); 2g/day for 8 weeks (Hashimoto's thyroiditis); 0.5-2g powder/day for 4 weeks (healthy volunteers); 40mg/kg/day for 3 months (pediatric leukemia). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cinnamon, Berberine, Alpha-Lipoic Acid, Turmeric, Omega-3

Safety & Interactions

Nigella sativa is generally well tolerated at doses up to 3g/day, with the most commonly reported side effects being mild gastrointestinal discomfort, nausea, and bloating. Thymoquinone inhibits CYP2D6 and CYP3A4 enzymes in vitro, raising potential interaction concerns with drugs metabolized by these pathways, including certain antidepressants, statins, and immunosuppressants. Due to its blood glucose-lowering effects, concurrent use with antidiabetic medications such as metformin or insulin may increase hypoglycemia risk and warrants monitoring. Nigella sativa is not recommended during pregnancy at therapeutic doses, as animal studies suggest possible uterotonic effects; safety in breastfeeding has not been established.